Patents by Inventor Ana Ruiz

Ana Ruiz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Random access sensor with individually addressable transistors
    Patent number: 11758257
    Abstract: A circuit, e.g., a CMOS sensor, with individually addressable transfer transistors and individually addressable reset transistors is described. Through the individually addressable transistors, pixels within different regions of interest, of the same or different size and/or the same or different exposure times, can be efficiently processed. Different regions of interest may be exposed concurrently and read out independently.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: September 12, 2023
    Assignee: PerkinElmer U.S. LLC
    Inventors: Charles Adams Schneider, Jr., Brian Klembara, Rafael Domínguez Castro, Jesús Ruiz Amaya, Jose Angel Segovia de la Torre, Bruno Gili, Ana González Márquez
  • Norethindrone sustained release formulations and methods associated therewith
    Publication number: 20050058695
    Abstract: Sustained delivery formulations of norethindrone are disclosed and described. In one aspect, the formulation may be a transdermal formulation that includes both norethindrone and norethindrone acetate. In another aspect, the formulation may further include a penetration enhancer. Coadministration of norethindrone and norethindrone acetate has been found to provide a number of advantages, such as achievement of peak norethindrone serum levels substantially within 24 hours after initiation of administration.
    Type: Application
    Filed: December 17, 2003
    Publication date: March 17, 2005
    Inventors: Angela Anigbogu, Ana Ruiz, Danyi Quan
  • Norethindrone sustained release formulations and methods associated therewith
    Publication number: 20040037873
    Abstract: Sustained delivery formulations of norethindrone are disclosed and described. In one aspect, the formulation may be a transdermal formulation that includes both norethindrone and norethindrone acetate. In another aspect, the formulation may further include a penetration enhancer. Coadministration of norethindrone and norethindrone acetate has been found to provide a number of advantages, such as achievement of peak norethindrone serum levels substantially within 24 hours after initiation of administration.
    Type: Application
    Filed: May 30, 2003
    Publication date: February 26, 2004
    Applicant: WATSON PHARMACEUTICALS, INC.
    Inventors: Angela Anigbogu, Ana Ruiz, Danyi Quan
  • Nail compositions and methods of administering same
    Patent number: 6585963
    Abstract: Nail compositions and methods of use thereof are disclosed. Additionally, nail kits comprising a nail composition and pre-treatment compositions are disclosed. Further, supportive devices such as bandages for use in the administering a nail composition are disclosed. In one aspect of the invention, the nail compositions comprise an antifungal agent, including fluconazole, a non-cellulosic polymeric carrier, and an enhancer, while being substantially free of urea, sulfhydryl-containing amino acids, or vasodilators.
    Type: Grant
    Filed: April 10, 2001
    Date of Patent: July 1, 2003
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Danyi Quan, Ana Ruiz
  • Musical baby spoon
    Patent number: D339505
    Type: Grant
    Filed: January 28, 1992
    Date of Patent: September 21, 1993
    Inventor: Ana Ruiz